Cargando…
Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355412/ https://www.ncbi.nlm.nih.gov/pubmed/28303487 http://dx.doi.org/10.1186/s13550-017-0270-7 |
| _version_ | 1782515557963137024 |
|---|---|
| author | Sabour, Siamak |
| author_facet | Sabour, Siamak |
| author_sort | Sabour, Siamak |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5355412 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53554122017-03-30 Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients Sabour, Siamak EJNMMI Res Letter to the Editor Springer Berlin Heidelberg 2017-03-16 /pmc/articles/PMC5355412/ /pubmed/28303487 http://dx.doi.org/10.1186/s13550-017-0270-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Sabour, Siamak Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients |
| title | Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients |
| title_full | Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients |
| title_fullStr | Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients |
| title_full_unstemmed | Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients |
| title_short | Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients |
| title_sort | reproducibility of 18f-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355412/ https://www.ncbi.nlm.nih.gov/pubmed/28303487 http://dx.doi.org/10.1186/s13550-017-0270-7 |
| work_keys_str_mv | AT saboursiamak reproducibilityof18ffluoromisonidazoleintratumourdistributioninnonsmallcelllungcancermethodologicalissuestoavoidmismanagementofthepatients |